{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05501678",
            "orgStudyIdInfo": {
                "id": "IRB-66941"
            },
            "secondaryIdInfos": [
                {
                    "id": "1P50HD109861",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1P50HD109861"
                }
            ],
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Trial of Diphenhydramine for Sleep in Children With Autism",
            "officialTitle": "Randomized Placebo-controlled Crossover Trial of Diphenhydramine for Sleep in Children With Autism",
            "therapeuticArea": [
                "Other"
            ],
            "study": "trial-of-diphenhydramine-for-sleep-in-children-with-autism"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-09",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-12",
            "studyFirstSubmitQcDate": "2022-08-12",
            "studyFirstPostDateStruct": {
                "date": "2022-08-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-30",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Antonio Hardan",
                "investigatorTitle": "Professor of Psychiatry and Behavioral Sciences",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to examine the effect of diphenhydramine on sleep in children and adolescents with Autism Spectrum Disorder (ASD). Diphenhydramine is an anti-histaminergic agent with strong hypnotic properties. To accomplish this, the investigators will use a randomized double-blind placebo-controlled crossover 8-week study design to examine the effect of diphenhydramine on sleep physiology as assessed by polysomnography (PSG), actigraphy, circadian rhythm, and clinical measures."
        },
        "conditionsModule": {
            "conditions": [
                "Autism",
                "Autism Spectrum Disorder"
            ],
            "keywords": [
                "Diphenhdramine",
                "Sleep",
                "clinical trial",
                "autism"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 26,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Diphenhydramine, then Placebo",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will first receive Diphenhydramine for a 4-week period. A 25 mg dose of Diphenhydramine will be given at bedtime for one week and then will increase to 50 mg if needed and if well tolerated.\n\nParticipants will then receive Placebo (fake tablet) for a 4-week period. A 25 mg dose of matching Placebo will be given at bedtime for one week and then will increase to 50 mg if needed and if well tolerated.",
                    "interventionNames": [
                        "Drug: Diphenhydramine",
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Placebo, then Diphenhydramine",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will first receive Placebo (fake tablet) for a 4-week period. A 25 mg dose of matching Placebo will be given at bedtime for one week and then will increase to 50 mg if needed and if well tolerated.\n\nParticipants will then receive Diphenhydramine for a 4-week period. A 25 mg dose of Diphenhydramine will be given at bedtime for one week and then will increase to 50 mg if needed and if well tolerated.",
                    "interventionNames": [
                        "Drug: Diphenhydramine",
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Diphenhydramine",
                    "description": "25mg (and up to 50mg) Diphenhydramine given orally",
                    "armGroupLabels": [
                        "Diphenhydramine, then Placebo",
                        "Placebo, then Diphenhydramine"
                    ],
                    "otherNames": [
                        "Benadryl"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Matching Placebo given orally",
                    "armGroupLabels": [
                        "Diphenhydramine, then Placebo",
                        "Placebo, then Diphenhydramine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change from baseline in sleep latency as measured by polysomnography (PSG)",
                    "timeFrame": "Baseline, Week 4 and Week 8"
                },
                {
                    "measure": "Change from baseline in duration of non-rapid eye movement (NREM) sleep as measured by polysomnography (PSG)",
                    "timeFrame": "Baseline, Week 4 and Week 8"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in sleep efficiency as measured by polysomnography (PSG) and actigraphy",
                    "timeFrame": "Baseline, Week 4 and Week 8"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Change from baseline on Children's Sleep Habits Questionnaire (CSHQ) subscale scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Aberrant Behavior Checklist, Second Edition (ABC-2) subscale scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Parent Sleep Habits Questionnaire Parent (PSHQ) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Clinical Global Impression Scale (CGI) scores",
                    "timeFrame": "Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 6, Week 7, and Week 8"
                },
                {
                    "measure": "Change from baseline on Child Behavior Checklist (CBCL) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Social Responsiveness Scale, Second Edition (SRS-2) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Repetitive Behavior Scale - Revised (RBS-R) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Sensory Profile Questionnaire (SPQ) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Stanford Social Dimension Scale (SSDS) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on Dimensional Assessment of Repetitive Behaviors (DARB) scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                },
                {
                    "measure": "Change from baseline on NEuroPSYchological Assessment, 2nd Edition (NEPSY-2) Affect Recognition scores",
                    "timeFrame": "Baseline, Week 4, Week 8"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria:\n\nParticipants will meet the following\n\n* Outpatients between 8 and 17 years of age\n* Diagnostic and Statistical Manual, 5th edition (DSM-5) criteria for Autism Spectrum Disorder (ASD) on the basis of clinical evaluation, confirmed with the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule, 2nd Ed (ADOS-2)\n* Males and females\n* Availability of polysomnography (PSG) and actigraphy data\n* Sleep disturbances as assessed using Children's Sleep Habits Questionnaire (CSHQ) with a score of 41 or higher\n* care provider who can reliably bring participant to clinic visits, provide trustworthy ratings, and interacts with participant on a regular basis\n* stable medications for at least 4 weeks\n* no planned changes in psychosocial and biomedical interventions during the trial\n* willingness to provide additional saliva samples and participate in key study procedures (i.e.,safety measurements every visit, PSG at weeks 4 and 8, and wear the actigraphy watch for 2 weeks before the beginning of trial as well as during the 8 weeks of the trial).\n\nExclusion criteria:\n\nParticipants will be excluded if one or more of the following is met\n\n* active suicidal ideation or DSM-5 diagnosis of schizophrenia, schizoaffective disorder, or psychotic disorder\n* active medical problems: migraine, asthma, seizure disorder, significant physical illness (e.g., anaphylaxis, serious liver, renal, or cardiac pathology)\n* evidence of a genetic mutation known to cause autism or intellectual disability (e.g., Fragile X Syndrome), metabolic, or infectious etiology for the participant's autism on the basis of medical history, neurologic history, and available tests for inborn errors of metabolism and chromosomal analysis\n* pregnant or sexually active females not using a reliable method of contraception (urinary tests for pregnancy will be employed in this study)\n* individuals taking beta-blockers (local or systemic), benzodiazepines, antiepileptic medications, melatonin and antihistamines\n* history of hypersensitivity to diphenhydramine\n* history of severe side effects from diphenhydramine\n* history of adequate trial of diphenhydramine\n* current use of any medications known to interact with diphenhydramine such as medications inhibiting CYP2D6\n* taking anticholinergic agents (e.g., trihexyphenidyl, thioridazine).",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "8 Years",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Briana Hernandez",
                    "role": "CONTACT",
                    "phone": "(650)736-1235",
                    "email": "acesleepstudy@stanford.edu"
                },
                {
                    "name": "Robin Libove",
                    "role": "CONTACT",
                    "phone": "(650)736-1235",
                    "email": "rlibove@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Antonio Y. Hardan, MD",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305-5719",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Briana Hernandez",
                            "role": "CONTACT",
                            "phone": "650-736-1235",
                            "email": "acesleepstudy@stanford.edu"
                        },
                        {
                            "name": "Robin Libove",
                            "role": "CONTACT",
                            "phone": "(650) 736-1235",
                            "email": "rlibove@stanford.edu"
                        },
                        {
                            "name": "Antonio Y. Hardan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "We will submit de-identified clinical data to the NIMH Data Archive (NDA) data repository.",
            "url": "https://nda.nih.gov/nda/data-contribution.html"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001321",
                    "term": "Autistic Disorder"
                },
                {
                    "id": "D000067877",
                    "term": "Autism Spectrum Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002659",
                    "term": "Child Development Disorders, Pervasive"
                },
                {
                    "id": "D000065886",
                    "term": "Neurodevelopmental Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4623",
                    "name": "Autistic Disorder",
                    "asFound": "Autism",
                    "relevance": "HIGH"
                },
                {
                    "id": "M206",
                    "name": "Autism Spectrum Disorder",
                    "asFound": "Autism Spectrum Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5903",
                    "name": "Child Development Disorders, Pervasive",
                    "relevance": "LOW"
                },
                {
                    "id": "M5902",
                    "name": "Developmental Disabilities",
                    "relevance": "LOW"
                },
                {
                    "id": "M30644",
                    "name": "Neurodevelopmental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004155",
                    "term": "Diphenhydramine"
                },
                {
                    "id": "D000011398",
                    "term": "Promethazine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000068776",
                    "term": "Sleep Aids, Pharmaceutical"
                },
                {
                    "id": "D000006993",
                    "term": "Hypnotics and Sedatives"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000779",
                    "term": "Anesthetics, Local"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000006634",
                    "term": "Histamine H1 Antagonists"
                },
                {
                    "id": "D000006633",
                    "term": "Histamine Antagonists"
                },
                {
                    "id": "D000018494",
                    "term": "Histamine Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018926",
                    "term": "Anti-Allergic Agents"
                },
                {
                    "id": "D000000982",
                    "term": "Antipruritics"
                },
                {
                    "id": "D000003879",
                    "term": "Dermatologic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17544",
                    "name": "Vitamin A",
                    "relevance": "LOW"
                },
                {
                    "id": "M14268",
                    "name": "Promethazine",
                    "asFound": "Reserve",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7338",
                    "name": "Diphenhydramine",
                    "asFound": "Reserve",
                    "relevance": "HIGH"
                },
                {
                    "id": "M302395",
                    "name": "Retinol palmitate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10043",
                    "name": "Hypnotics and Sedatives",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4109",
                    "name": "Anesthetics, Local",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9708",
                    "name": "Histamine",
                    "relevance": "LOW"
                },
                {
                    "id": "M9710",
                    "name": "Histamine H1 Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M212144",
                    "name": "Histamine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M9709",
                    "name": "Histamine Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20962",
                    "name": "Anti-Allergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7074",
                    "name": "Dermatologic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T468",
                    "name": "Vitamin A",
                    "relevance": "LOW"
                },
                {
                    "id": "T462",
                    "name": "Retinol",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AAll",
                    "name": "Anti-Allergic Agents"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}